NEW YORK (GenomeWeb News) – Quest Diagnostics today reported a 4 percent drop year over year in fourth-quarter sales as Hurricane Sandy shrank revenues by $21 million.

For the three months ended Dec. 31, 2012, revenues totaled $1.77 billion, down from $1.85 billion a year ago and short of the consensus Wall Street estimate of $1.80 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.